Xios Therapeutics
Waltham
About Xios Therapeutics
Xios Therapeutics is a biotechnology company developing novel small molecule therapeutics capable of preventing tumors from evading the immune system. The company focuses on immuno-oncology pathways and mechanisms that can be best targeted by small molecule therapeutics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.0M
- Last round: Series Unknown (Jul 2018)
- Website: xiostx.com
Industries & Categories
Biotechnology, Health Care, Medical Device, Therapeutics
Canonical: https://fsome.com/organization/xios-therapeutics-144462 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.